High-throughput screening campaigns against a PI3Kα isoform bearing the H1047R mutation identified potential inhibitors with novel scaffolds
文献类型:期刊论文
作者 | Jia Wang4![]() |
刊名 | 中国药理学报:英文版
![]() |
出版日期 | 2018 |
卷号 | 39.0期号:011页码:1816 |
关键词 | 脚手架 屏蔽 识别 产量 运动 类脂化合物 混合物 新陈代谢 |
ISSN号 | 1671-4083 |
英文摘要 | The phosphatidylinositol 3-kinase (PI3K) pathway is involved in many cellular functions including cell growth, metabolism, and transformation. Hyperactivation of this pathway contributes to tumorigenesis, therefore, PI3K is a major target for anticancer drug discover. Since the PI3Ka isoform is implicated mostly in cancer, we conducted a high-throughput screening (HTS) campaign using a 3-step PI3K homogenous time-resolved fluorescence assay against this isoform bearing the H1047R mutation. A total of 288,000 synthetic and natural product-derived compounds were screened and of which, we identified 124 initial hits that were further selected by considering the predicted binding mode, relationship to known pan-assay interference compounds and previous descriptions as a lipid kinase inhibitor. A total of 24 compounds were then tested for concentration-dependent responses. These hit compounds provide novel scaffolds that can potentially be optimized to create novel PI3K inhibitors. |
语种 | 英语 |
源URL | [http://119.78.100.183/handle/2S10ELR8/294527] ![]() |
专题 | 中国科学院上海药物研究所 |
作者单位 | 1.Auckland Cancer Society Research Centre 2.The Maurice Wilkins Centre 3.奥克兰大学 4.中国科学院上海药物研究所 |
推荐引用方式 GB/T 7714 | Jia Wang,Grace Qun Gong,Yan Zhou,et al. High-throughput screening campaigns against a PI3Kα isoform bearing the H1047R mutation identified potential inhibitors with novel scaffolds[J]. 中国药理学报:英文版,2018,39.0(011):1816. |
APA | Jia Wang.,Grace Qun Gong.,Yan Zhou.,WooJeong Lee.,Christina Maree Buchanan.,...&MingWei Wang.(2018).High-throughput screening campaigns against a PI3Kα isoform bearing the H1047R mutation identified potential inhibitors with novel scaffolds.中国药理学报:英文版,39.0(011),1816. |
MLA | Jia Wang,et al."High-throughput screening campaigns against a PI3Kα isoform bearing the H1047R mutation identified potential inhibitors with novel scaffolds".中国药理学报:英文版 39.0.011(2018):1816. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。